Prevention of cardiotoxicity in adjuvant breast cancer (BC) therapy

被引：0
|
作者：
Tomassi, O. M. [1 ]
Giovinazzo, P. [2 ]
Barro, S. [2 ]
Milani, L. [2 ]
Bernardi, D. [3 ]
机构：
[1] ULSS 10 Veneto Orientale, San Dona Di Piave, VE, Italy
[2] ULSS 10 Veneto Orientale, Cardiol, San Dona Di Piave, VE, Italy
[3] ULSS 10 Veneto Orientale, Oncol, San Dona Di Piave, VE, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A50
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [21] Adjuvant therapy for breast cancer
    Rodenhuis, S.
    Rutgers, E. J. T.
    [J]. BRITISH JOURNAL OF SURGERY, 2006, 93 (12) : 1443 - 1445
  • [22] Cardiotoxicity risks of adjuvant trastuzumab in Asian breast cancer patients
    Shih, V.
    Chan, A.
    Chiang, J.
    Teo, C.
    Chen, J.
    Wong, Z.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Preventing Cardiotoxicity Associated With Breast Cancer Therapy
    Slomski, Anita
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (04): : 296 - 296
  • [24] Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings
    Ingle, JN
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (02) : 900S - 905S
  • [25] Prevention of cardiac dysfunction during adjuvant breast cancer therapy: the PRADA study
    Gulati, Geeta
    Heck, Siri Lagethon
    Ree, Anne Hansen
    Bratland, Ase
    Steine, Kjetil
    Schulz-Menger, Jeanette
    Gravdehaug, Berit
    Hoffmann, Pavel
    Rosjo, Helge
    Geisler, Jurgen
    Omland, Torbjorn
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [26] Right Ventricular Dysfunction is Common in Patients With Breast Cancer Experiencing Cardiotoxicity During Adjuvant Trastuzumab Therapy
    Calleja, Anna
    Poulin, Frederic
    McDonald, Michael
    Delgado, Diego H.
    Thavendiranathan, Paaladinesh
    [J]. CIRCULATION, 2013, 128 (22)
  • [27] Cardiotoxicity associated with cancer therapy: Pathophysiology and prevention strategies
    Adao, Rui
    de Keulenaer, Gilles
    Leite-Moreira, Adelino
    Bras-Silva, Carmen
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2013, 32 (05) : 395 - 409
  • [28] Benefit with adjuvant taxanes and endocrine responsiveness in breast cancer (BC)
    Martin, M.
    [J]. BREAST, 2007, 16 : S9 - S10
  • [29] Cardiotoxicity Risks of Adjuvant Trastuzumab in Asian Breast Cancer Patients.
    Shih, V.
    Chan, A.
    Sim, M. H.
    Teo, C.
    Chen, W.
    Wong, Z. W.
    [J]. CANCER RESEARCH, 2011, 71
  • [30] Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guideline update: adjuvant therapy for triple negative breast cancer in 2022
    Ding, Hua
    Zhang, Li
    Wang, Yue
    Liu, Shu
    [J]. TRANSLATIONAL BREAST CANCER RESEARCH, 2022, 3
12345